Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
  • Articles
  • Law Firms
  • Law Firms
  • Organizations
  • Organizations
    • TOP STORY—TTAB: USPTO cancels six Washington Redskins marks as disparaging to Native Americans
    • COPYRIGHT—C.D. Cal.: Cross motions for summary judgment denied in dispute over rights to skull designs
    • COPYRIGHT—M.D. Tenn.: Songwriters accused of infringement pleaded plausible counterclaims for breach of covenant not to sue
    • COPYRIGHT—N.D. Ill.: Lady Gaga’s song “Judas” was not substantially similar to plaintiff’s song “Juda”
    • LAW FIRM NEWS: Howard Suh joins Holland & Knight in New York
    • PATENT NEWS: USPTO proposes changes to patent term adjustment rules in light of Federal Circuit’s Novartis decision
    • PATENT—E.D. Va.: Partial limited stay granted for CBM review of buySAFE’s patent in dispute with Google
    • PATENT—N.D. Cal.: Jury’s award of $3.82 million in damages to Realtek for LSI’s breach of contract upheld
    • TRADEMARK—N.D. Tex.: Owner of cellular performance-analysis software could not pursue infringement claims against former licensee
  • Articles
  • Articles
  • Law Firms
  • Law Firms
  • Organizations
  • Organizations

    IP Law Daily, PATENT NEWS: USPTO proposes changes to patent term adjustment rules in light of Federal Circuit’s Novartis decision, (Jun 18, 2014)

    By Cheryl Beise, J.D.

    The USPTO has issued a notice seeking comments on proposed changes to the agency’s patent rules of practice pertaining to the patent term adjustment provisions (79 Fed. Reg. 34682, June 18, 2014) in light of the Federal Circuit’s Januar ...

    By Cheryl Beise, J.D.

    The USPTO has issued a notice seeking comments on proposed changes to the agency’s patent rules of practice pertaining to the patent term adjustment provisions (79 Fed. Reg. 34682, June 18, 2014) in light of the Federal Circuit’s January 15, 2014 decision in Novartis AG v. Lee, clarifying the effect of continued examination on the rules pertaining to patent term adjustments.

    In Novartis, the Federal Circuit held that any time consumed by continued examination under 35 U.S.C. §132(b) is subtracted when determining the extent to which the period defined in 35 U.S.C. §154(b)(1)(B) exceeds three years, regardless when the continued examination under 35 U.S.C. §132(b) was initiated. The Federal Circuit also ruled that the time consumed by continued examination under 35 U.S.C. §132(b) does not include the time after a notice of allowance unless the Office actually resumes examination of the application after allowance.

    The USPTO is proposing to amend 37 CFR §1.703 to provide that the time consumed by continued examination under 35 U.S.C. §132(b) does not include the time after a notice of allowance, unless the Office actually resumes examination of the application after allowance. This rule is intended to ensure that an applicant does not obtain multiple periods of patent term adjustment under 35 U.S.C. §154(b)(1)(B) as a consequence of delaying the issuance of the application by filing request(s) for continued examination under 35 U.S.C. §132(b) following the issuance of a notice of allowance under 35 U.S.C. §151.

    The agency also is proposing to amend 37 CFR §1.704 to include a provision that establishes that the submission of a request for continued examination under 35 U.S.C. §132(b) after a notice of allowance under 35 U.S.C. §151 has been mailed will constitute a failure of an applicant to engage in reasonable efforts to conclude the processing or examination of an application and thus will result in a reduction of any period of patent term adjustment under 35 U.S.C. §154(b)(1).

    Written comments on the proposed rule changes must be received on or before August 18, 2014. More information about the proposed rulemaking and instructions for submitting comments is available in the notice.

    News: Patent USPTO

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use